Controller-managed automated antiangiogenic cancer therapy
8 Angebote vergleichen

Von Händler/Antiquariat, AHA-BUCH GmbH [51283250], Einbeck, Germany.
This item is printed on demand - Print on Demand Titel. Neuware - The key of scientific success in every field nowadays depends on interdisciplinary design. Medical treatment is not an exception either; engineers and doctors have to work together to find more effective solutions in healing. In the clinical practice, there are general protocols for cancer therapies (such as chemotherapy, radiotherapy); however, these treatments have many side effects. That is the reason why a new dynamically-developing therapeutic group called Targeted Molecular Therapies (TMTs) has appeared, which fight specifically against different cancer mechanisms. Using physiological modeling and control, one can desig closed-loop control systems, hence the protocols could become model-based, which enables the automated treatment of cancer diseases by the personalized administration of TMT drugs. In this way, more effective solutions can be found in healing and offering individualized treatment for the patient. This approach is completely novel and may lead to a breakthrough in cancer therapies. Optimizing cancer treatments would improve efficiency, decrease treatment cost and minimize the side effects of cancer therapy (i.e. improves the patient's quality of life). 160 pp. Englisch.

Von Händler/Antiquariat, The Book Depository EURO [60485773], London, United Kingdom.
Language: English Brand New Book ***** Print on Demand *****.The key of scientific success in every field nowadays depends on interdisciplinary design. Medical treatment is not an exception either; engineers and doctors have to work together to find more effective solutions in healing. In the clinical practice, there are general protocols for cancer therapies (such as chemotherapy, radiotherapy); however, these treatments have many side effects. That is the reason why a new dynamically-developing therapeutic group called Targeted Molecular Therapies (TMTs) has appeared, which fight specifically against different cancer mechanisms. Using physiological modeling and control, one can desig closed-loop control systems, hence the protocols could become model-based, which enables the automated treatment of cancer diseases by the personalized administration of TMT drugs. In this way, more effective solutions can be found in healing and offering individualized treatment for the patient. This approach is completely novel and may lead to a breakthrough in cancer therapies. Optimizing cancer treatments would improve efficiency, decrease treatment cost and minimize the side effects of cancer therapy (i.e. improves the patient s quality of life).

Lieferung aus: Österreich, Versandfertig in 4 - 6 Tagen.
The key of scientific success in every field nowadays depends on interdisciplinary design. Medical treatment is not an exception either; engineers and doctors have to work together to find more effective solutions in healing. In the clinical practice, there are general protocols for cancer therapies (such as chemotherapy, radiotherapy); however, these treatments have many side effects. That is the reason why a new dynamically-developing therapeutic group called Targeted Molecular Therapies (TMTs) has appeared, which fight specifically against different cancer mechanisms. Using physiological modeling and control, one can desig closed-loop control systems, hence the protocols could become model-based, which enables the automated treatment of cancer diseases by the personalized administration of TMT drugs. In this way, more effective solutions can be found in healing and offering individualized treatment for the patient. This approach is completely novel and may lead to a breakthrough in cancer therapies. Optimizing cancer treatments would improve efficiency, decrease treatment cost and minimize the side effects of cancer therapy (i.e. improves the patient's quality of life). Taschenbuch, 12.07.2015.

Lieferung aus: Deutschland, zzgl. Versandkosten.
The key of scientific success in every field nowadays depends on interdisciplinary design. Medical treatment is not an exception either; engineers and doctors have to work together to find more effective solutions in healing. In the clinical practice, there are general protocols for cancer therapies (such as chemotherapy, radiotherapy); however, these treatments have many side effects. That is the reason why a new dynamically-developing therapeutic group called Targeted Molecular Therapies (TMTs) has appeared, which fight specifically against different cancer mechanisms. Using physiological modeling and control, one can desig closed-loop control systems, hence the protocols could become model-based, which enables the automated treatment of cancer diseases by the personalized administration of TMT drugs. In this way, more effective solutions can be found in healing and offering individualized treatment for the patient. This approach is completely novel and may lead to a breakthrough in cancer therapies. Optimizing cancer treatments would improve efficiency, decrease treatment cost and minimize the side effects of cancer therapy (i.e. improves the patient's quality of life).

Lieferung aus: Österreich, Lieferzeit: 5 Tage, zzgl. Versandkosten.
The key of scientific success in every field nowadays depends on interdisciplinary design. Medical treatment is not an exception either, engineers and doctors have to work together to find more effective solutions in healing. In the clinical practice, there are general protocols for cancer therapies (such as chemotherapy, radiotherapy), however, these treatments have many side effects. That is the reason why a new dynamically-developing therapeutic group called Targeted Molecular Therapies (TMTs) has appeared, which fight specifically against different cancer mechanisms. Using physiological modeling and control, one can desig closed-loop control systems, hence the protocols could become model-based, which enables the automated treatment of cancer diseases by the personalized administration of TMT drugs. In this way, more effective solutions can be found in healing and offering individualized treatment for the patient. This approach is completely novel and may lead to a breakthrough in cancer therapies. Optimizing cancer treatments would improve efficiency, decrease treatment cost and minimize the side effects of cancer therapy (i.e. improves the patient's quality of life).

Lieferung aus: Deutschland, Versandkostenfrei.
Controller-managed automated antiangiogenic cancer therapy: The key of scientific success in every field nowadays depends on interdisciplinary design. Medical treatment is not an exception either engineers and doctors have to work together to find more effective solutions in healing. In the clinical practice, there are general protocols for cancer therapies (such as chemotherapy, radiotherapy) however, these treatments have many side effects. That is the reason why a new dynamically-developing therapeutic group called Targeted Molecular Therapies (TMTs) has appeared, which fight specifically against different cancer mechanisms. Using physiological modeling and control, one can desig closed-loop control systems, hence the protocols could become model-based, which enables the automated treatment of cancer diseases by the personalized administration of TMT drugs. In this way, more effective solutions can be found in healing and offering individualized treatment for the patient. This approach is completely novel and may lead to a breakthrough in cancer therapies. Optimizing cancer treatments would improve efficiency, decrease treatment cost and minimize the side effects of cancer therapy (i.e. improves the patient`s quality of life). Englisch, Taschenbuch.

Lieferung aus: Vereinigte Staaten von Amerika, zzgl. Versandkosten, Free Shipping on eligible orders over $25, in-stock.
S jevicsn S pi Johanna, Paperback, English-language edition, Pub by OmniScriptum GmbH & Co. KG.